Ryan J. Stubbins

619 total citations
26 papers, 286 citations indexed

About

Ryan J. Stubbins is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Ryan J. Stubbins has authored 26 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Ryan J. Stubbins's work include Acute Myeloid Leukemia Research (11 papers), Viral-associated cancers and disorders (6 papers) and Otitis Media and Relapsing Polychondritis (5 papers). Ryan J. Stubbins is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Viral-associated cancers and disorders (6 papers) and Otitis Media and Relapsing Polychondritis (5 papers). Ryan J. Stubbins collaborates with scholars based in Canada, United States and Australia. Ryan J. Stubbins's co-authors include Aly Karsan, Florian Kuchenbauer, David Sanford, Thomas J. Nevill, Luke Y. C. Chen, Lorena Wilson, Daniela Ospina Cardona, Uwe Platzbecker, Lucy A. Godley and Anthea Peters and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Ryan J. Stubbins

21 papers receiving 283 citations

Peers

Ryan J. Stubbins

HEMAT

RHEUM

GENET

ONCOL

Cecilia Arana Yi United States

Diego Quinones Raffo United States

Gaku Oshikawa Japan

TRDJ Radstake Netherlands

Martine Klausmann Germany

Liwei Fang China

Mary Alikian United Kingdom

Rossana Putzulu Italy

Sung‐Soo Yoon South Korea

Cornelis E. Hack Netherlands

Cecilia Arana Yi United States

Ryan J. Stubbins

100 ×1.0

HEMAT

80 ×0.9

35 ×0.4

RHEUM

71 ×0.9

GENET

55 ×0.7

ONCOL

Citations per year, relative to Ryan J. Stubbins Ryan J. Stubbins (= 1×) peers Cecilia Arana Yi

Countries citing papers authored by Ryan J. Stubbins

Since Specialization

Citations

This map shows the geographic impact of Ryan J. Stubbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan J. Stubbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan J. Stubbins more than expected).

Fields of papers citing papers by Ryan J. Stubbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan J. Stubbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan J. Stubbins. The network helps show where Ryan J. Stubbins may publish in the future.

Co-authorship network of co-authors of Ryan J. Stubbins

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan J. Stubbins. A scholar is included among the top collaborators of Ryan J. Stubbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan J. Stubbins. Ryan J. Stubbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Jihong, Vijay Suresh Akhade, Joshua Bridgers, et al.. (2025). Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm. Leukemia. 39(4). 917–928.

Stubbins, Ryan J., Stephen Arnovitz, Imo J. Akpan, et al.. (2025). Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants. Leukemia. 39(7). 1702–1713.

Chung, Shanee, Donna L. Forrest, Florian Kuchenbauer, et al.. (2025). Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years. Transplantation and Cellular Therapy. 31(2). S50–S51.

Chen, Dennis, et al.. (2025). Kaposi sarcoma posthematopoietic stem cell transplant for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. JAAD Case Reports. 58. 56–59. 1 indexed citations

Stubbins, Ryan J., et al.. (2024). Optical Genome Mapping As Standard-of-Care in Acute Leukemia: Diagnostic and Clinical Impacts 10 Months Post-Implementation. Blood. 144(Supplement 1). 1538–1538.

Murphy, Stephen F., Rebecca A. Harrison, Erica A. Peterson, et al.. (2024). Rosai-Dorfman-Destombes disease in adults: a single center experience. Annals of Hematology. 103(11). 4467–4476. 1 indexed citations

Stubbins, Ryan J., et al.. (2024). Cellular and immunotherapies for myelodysplastic syndromes. Seminars in Hematology. 61(6). 397–408.

Wan, Bo, Yasser Abou Mourad, Shanee Chung, et al.. (2024). Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products. Cytotherapy. 26(10). 1210–1216. 2 indexed citations

Stubbins, Ryan J., et al.. (2023). A young woman with persistent sore throat, Epstein–Barr virus, lymphadenopathy, and aberrant CD4 + CD7‐ T‐cells. American Journal of Hematology. 98(5). 824–829. 1 indexed citations

10.

Kuchenbauer, Florian, Ryan J. Stubbins, Shanee Chung, et al.. (2023). Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort. Blood. 142(Supplement 1). 1482–1482. 3 indexed citations

11.

Dehghan, Natasha, Ryan J. Stubbins, Lynda Foltz, et al.. (2023). VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation. European Journal Of Haematology. 110(6). 633–638. 14 indexed citations

12.

Stubbins, Ryan J., Uwe Platzbecker, & Aly Karsan. (2022). Inflammation and myeloid malignancy: quenching the flame. Blood. 140(10). 1067–1074. 25 indexed citations

13.

Stubbins, Ryan J., et al.. (2022). Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. Canadian Medical Association Journal. 194(14). E524–E527. 8 indexed citations

14.

Stubbins, Ryan J., et al.. (2022). Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies. Current Hematologic Malignancy Reports. 17(4). 94–104. 18 indexed citations

15.

Stubbins, Ryan J., Sunita Ghosh, John Kuruvilla, et al.. (2022). Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders. Clinical Lymphoma Myeloma & Leukemia. 22(10). 744–752. 2 indexed citations

16.

Stubbins, Ryan J. & Aly Karsan. (2021). Differentiation therapy for myeloid malignancies: beyond cytotoxicity. Blood Cancer Journal. 11(12). 193–193. 39 indexed citations

17.

Stubbins, Ryan J., Irina A. Maksakova, David Sanford, A. MAUREEN ROUHI, & Florian Kuchenbauer. (2021). Mitochondrial metabolism: powering new directions in acute myeloid leukemia. Leukemia & lymphoma. 62(10). 2331–2341. 9 indexed citations

18.

Stubbins, Ryan J., et al.. (2020). Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes. Leukemia & lymphoma. 61(14). 3319–3330. 6 indexed citations

19.

Stubbins, Ryan J., Anthea Peters, Simon Urschel, et al.. (2018). Epstein‐Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature. Transplant Infectious Disease. 21(1). e13010–e13010. 22 indexed citations

20.

Stubbins, Ryan J., et al.. (2016). A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use. BMC Research Notes. 9(1). 310–310. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact